Guess Who Just Picked Up Tailored Brands Inc. (NYSE:TLRD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Tailored Brands Inc. (NYSE:TLRD) reported that Park West Asset Management has picked up 872,100 of common stock as of 2017-02-21.
The acquisition brings the aggregate amount owned by Park West Asset Management to a total of 872,100 representing a 1.8% stake in the company.
For those not familiar with the company, Tailored Brands, Inc. is a holding company of The Men’s Wearhouse, Inc. The Company is a specialty apparel retailer offering suits, suit separates, sport coats, slacks, business casual, sportswear, outerwear, dress shirts, shoes and accessories for men and tuxedo and suit rental product. It operates through two segments: Retail and Corporate Apparel. The Retail segment includes over four retail merchandising brands: Men’s Wearhouse/Men’s Wearhouse and Tux, Jos. A. Bank, Moores, and K&G. Specialty apparel merchandise offered by its retail merchandising concepts include suits, suit separates, sport coats, business casual, sportswear, outerwear, dress shirts, shoes and accessories for men. Women’s career apparel, sportswear and accessories, such as shoes and children’s apparel, are offered at its K&G stores. The Corporate Apparel segment includes corporate apparel and uniform operations conducted by Twin Hill in the United States and Dimensions, Alexandra and Yaffy in the United Kingdom.
A glance at Tailored Brands Inc. (NYSE:TLRD)’s key stats reveals a current market capitalization of 1.13 billion based on 48.74 million shares outstanding and a price at last close of $22.85 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-01-30, Eminence picked up 1,110,000 at a purchase price of $20.00. This brings their total holding to 7,253,578 as of the date of the filing.
On the sell side, the most recent transaction saw Becker unload 2,723 shares at a sale price of $26.18. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Tailored Brands Inc. (NYSE:TLRD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Don’t Miss This Bullish Run on OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) shares rose 36.57% on Friday to $0.915 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.95. The company has a market cap of $128.82 million at 135.31 million shares outstanding.
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. As such, it is engaged in the research and development of cannabis-based medical products for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications.
The company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. It was engaged in two business activities: work with GUMI to commercialize and market the Company’s Electromagnetic Percussion Device, and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder migraines and a delivery system.
Last week, OWC Pharmaceutical Corp announced that it would be presenting at the Wall Street Conference, which will be held at the Hilton Doubletree Hotel and Conference Center in Deerfield Beach, Boca Raton, Florida, on Wednesday, March 1, 2017. This premiere conference in the venture capital arena and small-cap marketplace includes industry leaders from the hedge fund, investment banking, and private equity worlds, as well as sophisticated investors, who attend to discuss significant trends in the financial markets.
The Wall Street Conference is one of the leading conferences for small-cap investors and OWC is excited to be a part of it. OWC continues to make significant progress in the research and development of cannabis-centric medical treatments, specifically with our psoriasis cream, which is being readied for the U.S. and European markets. We are focused on having our products on the shelves in the MMJ states this year. I am very much looking forward to discussing the Company with conference attendees,” remarked Ziv Turner, OWC Pharmaceutical Corp’s VP Business development and Managing Director of One World Cannabis.
Member of the company’s Advisory Board, Jeffrey Friedland, is a featured speaker at the Conference and is expected to discuss the opportunities for public company investments in the cannabis sector, and the positive impact that Israeli science and companies are having on the U.S. and Canadian cannabis markets. He is also CEO of Intiva Inc., which was an early-stage investor in OWC, and the author of Marijuana: The World‘s Most Misunderstood Plant.
The legal cannabis market has expanded considerably over the past two years, generating significant and growing investor interest. However, there are only a handful of publicly-traded companies focused on cannabinoid-based, pharmaceutical development and a true scientific approach to product development. I intend to discuss what I see as the publicly-traded cannabis opportunities at the Conference,” Friedland noted.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.